DekaBank Deutsche Girozentrale’s Catalyst Pharmaceutical CPRX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53M	Hold	183,376	–	–	0.01%	577
2025 Q4	$3.06M	Hold	183,376	–	–	0.01%	675
2025 Q3	$3.53M	Hold	183,376	–	–	0.01%	640
2025 Q2	$3.96M	Buy	183,376 +12,000	+7%	+$283K	0.01%	614
2025 Q1	$4.15M	Sell	171,376 -12,000	-7%	-$270K	0.01%	601
2024 Q4	$3.87M	Hold	183,376	–	–	0.01%	627
2024 Q3	$3.53M	Buy	183,376 +60,000	+49%	+$1.11M	0.01%	654
2024 Q2	$1.83M	Sell	123,376 -48,000	-28%	-$747K	﹤0.01%	778
2024 Q1	$2.76M	Buy	+171,376	New	+$2.58M	0.01%	694
2023 Q4	–	Sell	-20,000	Closed	-$236K	–	1484
2023 Q3	$236K	Buy	+20,000	New	+$268K	﹤0.01%	1161

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

DekaBank Deutsche Girozentrale's CPRX Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 183,376 shares worth $4.53M. The position accounts for 0.01% of the portfolio, ranked #577.

DekaBank Deutsche Girozentrale first reported a position in CPRX in Q3 2023 and has held it in 10 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

DekaBank Deutsche Girozentrale held 183,376 shares of Catalyst Pharmaceutical worth $4.53M as of Q1 2026.
DekaBank Deutsche Girozentrale left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
Catalyst Pharmaceutical made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #577 holding.
DekaBank Deutsche Girozentrale first reported a position in Catalyst Pharmaceutical in Q3 2023 and has held it in 10 quarters since.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.